FSP1 expression is significantly elevated in ccRCC compared to normal kidney tissue, and it can promote the occurrence and development of ccRCC by enhancing the ferroptosis defense system. The gene discussed is AIFM2; the disease is nonpapillary renal cell carcinoma.